After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback